Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.38 |
| ▸ | HPGD | P15428 | 2/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | MAPT | P10636 | 2/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | CA12 | O43570 | 1/20 | 0.38 |
| ▸ | CA1 | P00915 | 1/20 | 0.38 |
| ▸ | CA2 | P00918 | 1/20 | 0.38 |
| ▸ | CA7 | P43166 | 1/20 | 0.38 |
| ▸ | CA9 | Q16790 | 1/20 | 0.38 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 2/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.38 |
| ▸ | EGFR | P00533 | 3/20 | 0.37 |
| ▸ | PDGFRB | P09619 | 3/20 | 0.37 |
| ▸ | KDR | P35968 | 3/20 | 0.37 |
| ▸ | TUBB4A | P04350 | 2/20 | 0.37 |
| ▸ | TUBB | P07437 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6841187 | 0.95 | KDM4E (0.42) | HTTKDM4EHPGDALDH1A1MAPT | |
| SCHEMBL6746664 | 0.86 | HTT (0.39) | HTTKDM4EHPGDALDH1A1MAPT | |
| SCHEMBL6748661 | 0.84 | HTT (0.40) | HTTKDM4EHPGDALDH1A1MAPT | |
| SCHEMBL6848121 | 0.84 | CA1 (0.42) | HTTKDM4EHPGDALDH1A1MAPT | |
| SCHEMBL6856508 | 0.82 | TSHR (0.35) | ALDH1A1MEN1KMT2ANPC1RAB9A | |
| SCHEMBL6841147 | 0.82 | TSHR (0.35) | ALDH1A1MEN1KMT2ANPC1RAB9A | |
| SCHEMBL6850671 | 0.82 | ALDH1A1 (0.41) | KDM4EALDH1A1MAPTMEN1KMT2A | |
| SCHEMBL6748986 | 0.82 | KDM4E (0.42) | HTTKDM4EHPGDALDH1A1MAPT | |
| SCHEMBL6854371 | 0.81 | TP53 (0.35) | HTTKDM4EMAPTHSD17B10EGFR | |
| SCHEMBL6748390 | 0.80 | KDM4E (0.40) | HTTKDM4EHPGDALDH1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6696588-B2 | OXIDATION POTENTIAL OF .3-1.5 V ON THE BASIS OF A STANDARD HYDROGEN ELECTRODE, ALKOXY AND AROMATIC AMINE DERIVATIVES | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2004-02-24 | — | — | US | disclosed |
| EP-0861845-B1 | Silicon-containing compound and organic electroluminescence device using the same | SUMITOMO CHEMICAL CO (JP) | 2003-05-28 | — | — | EP | disclosed |
| US-20020115877-A1 | Silicon-containing compound and organic electroluminescence device using the same | SUMITOMO CHEMICAL COMPANY, LIMITED | 2002-08-22 | — | — | US | disclosed |
| US-6369258-B1 | SILICON COMPOUND WITH OXIDATION POTENTIAL ON HYDROGEN ELECTRODE POTENTIAL | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2002-04-09 | — | — | US | disclosed |
| EP-0861845-A2 | Silicon-containing compound and organic electroluminescence device using the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1998-09-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020115877-A1 | Silicon-containing compound and organic electroluminescence device using the same | EPCAM, PIEZO1, OR10J3 | HTT 3465/4885KDM4E 296/4885HPGD 4102/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.